Back

COMPASS Trial - Bleeding and cancer risk in patients with vascular disease treated with Rivaroxaban

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Clinical Trial Updates Secondary Prevention ESC Premium Access ESC Congress 2018

ESC TV

About the speaker

Photo
Doctor John William Eikelboom

McMaster University, Hamilton (Canada)

11 More presentations in this session

Presentation thumbnail
Discussant review - COMPASS.
Professor L. Wallentin (Uppsala, SE)
Slides Video
Presentation thumbnail
CANTOS - Modulation of the Interleukin-6 Signaling Pathway and Incidence Rates of Atherosclerotic Events and Mortality
Doctor P. Ridker (Boston, US)
Slides Video
Presentation thumbnail
Discussant review - CANTOS.
Professor M. Packer (Dallas, US)
Slides Video
Presentation thumbnail
CABANA Trial - Recurrence of Atrial Arrhythmias in the Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation
Professor J. Poole (Seattle, US)
Slides Video
Presentation thumbnail
Discussant review - CABANA.
Professor C. Leclercq (Rennes, FR)
Slides Video

Access the full session

Session thumbnail
Clinical Trial Updates

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Making personalised prevention everyone's business
thumbnail
Congress Presentation
Should we intervene early in patients with asymptomatic aortic stenosis?
thumbnail
Congress Presentation
Cardiovascular prevention in older adults

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources